Rosetta Genomics (ROSG) Announces that miRview IDs Small-Cell Lung Cancer with High Accuracy

January 13, 2010 7:44 AM EST Send to a Friend
Rosetta Genomics, Ltd. (NASDAQ: ROSG) announced today that the results of a joint study with the Department of Pathology at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login